Try our Advanced Search for more refined results
County of Summit, Ohio et al v. Purdue Pharma L.P. et al
Case Number:
1:18-op-45090
Court:
Nature of Suit:
Judge:
Firms
- Alston & Bird
- Arnold & Porter
- Baker & Hostetler
- Bartlit Beck
- Brennan Manna
- Buckingham Doolittle
- Cavitch Familo
- Covington & Burling
- Foley & Lardner
- Fox Rothschild
- Jones Day
- Kirkland & Ellis
- Locke Lord
- Marcus & Shapira
- Morgan Lewis
- Motley Rice
- O'Melveny & Myers
- Reed Smith
- Robbins Geller
- Ropes & Gray
- Williams & Connolly
- Zuckerman Spaeder
Companies
- Allergan PLC
- Anda Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Cephalon Inc.
- CVS Health Corp.
- Discount Drug Mart Inc.
- Endo International PLC
- Giant Eagle Inc.
- Henry Schein Inc.
- Johnson & Johnson
- Mallinckrodt PLC
- McKesson Corp.
- Noramco Inc.
- Par Pharmaceutical Cos. Inc.
- Purdue Pharma LP
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
- Walgreens Boots Alliance Inc.
- Walmart Inc.
- Warner Chilcott Limited
Sectors & Industries:
-
September 24, 2019
Opioid MDL Judge Rejects J&J's Attack On Trial Format
The Ohio federal judge overseeing multidistrict opioid litigation on Tuesday rejected Johnson & Johnson's bid for a bench trial instead of a jury trial on liability for an epidemic of painkiller addiction, saying "12 heads are better than one."
-
September 19, 2019
Jury's Task In Ohio Opioid MDL Trial Divides Drug Cos.
Drug companies involved in multidistrict opioid litigation voiced divergent views in Ohio federal court Thursday on the jury's role in a looming bellwether trial, a question with significant implications for a potential multibillion-dollar remedy.
-
September 06, 2019
Mallinckrodt Pays $24M To Exit Opioid MDL Bellwethers
Mallinckrodt said Friday it will pay $24 million and donate up to $6 million in generic drugs to resolve claims from two Ohio counties that are behind the lead bellwether cases in multidistrict litigation against opioid manufacturers.
-
September 03, 2019
Opioid MDL Jury Will Weigh 'Complete Failures' By Drug Cos.
A jury could find that "complete failures" by drug companies to stop illicit painkiller shipments unleashed a harrowing epidemic of addiction, an Ohio federal judge ruled Tuesday in the multidistrict opioid litigation's lead bellwether cases.
-
August 30, 2019
Ohio AG Asks 6th Circ. To Halt Upcoming Opioid Bellwether
Ohio's attorney general on Friday urged the Sixth Circuit to halt an upcoming bellwether trial that's part of multidistrict litigation against drugmakers blamed for the opioid crisis, calling the claims made by two Buckeye State counties in the bellwether case an "intrusion onto sovereign territory."
-
August 30, 2019
Allergan To Pay $5M To Exit Ohio Opioid Bellwethers
Allergan PLC on Friday said it had reached a $5 million settlement with two Ohio counties that are behind the lead bellwether cases in multidistrict opioid litigation.
-
April 26, 2019
Atty Sanctions Axed In Opioid MDL, Allowing Doc's Testimony
An Ohio federal judge on Friday scrapped attorney sanctions that would have barred testimony from a high-profile pain doctor in the multidistrict opioid litigation, calling the discipline "too extreme" despite a galling failure by plaintiffs' attorneys to divulge a deal with the doctor.
-
April 25, 2019
Opioid MDL Attys' Concealment Merited Sanction: Drug Cos.
Plaintiffs' attorneys who hid key witness testimony in the multidistrict opioid litigation were properly sanctioned by having that testimony blocked from a bellwether trial, drug companies told an Ohio federal court on Thursday.
-
April 18, 2019
Postpone Opioid MDL Trial? Get Real, Judge Says
An Ohio federal judge on Thursday said that drug companies in the multidistrict opioid litigation are apparently maneuvering to indefinitely delay a bellwether trial and that the idea isn't even worthy of consideration.
-
January 18, 2019
Drug Distributors Can't Appeal RICO Ruling In Opioid MDL
An Ohio federal judge on Friday blocked drug distributors from trying again to keep racketeering allegations out of a bellwether trial in the opioid multidistrict litigation, rejecting assertions that enormous damages associated with racketeering will hinder settlement talks.
- ← Previous
- 1
- 2
- 3
- Next →